Blog
Busting the myth that pen-and-paper is better than electronic outcome assessments
Clinical outcome assessments administered with pen-and-paper tasks have long been the assessment method of choice for measuring treatment effects on patients. However, with the advent of electronic alternatives - how do these two assessment methods compare?
Cambridge Cognition signs new eCOA contracts
Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.
web-based testing,
wearables,
voice,
virtual clinical trials,
technology,
swm,
stigma,
social cognition,
smartphones,
schizophrenia,
safety,
research funding,
research,
remote testing,
regulations,
recruitment,
prodromal,
pro-cognitive,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient-centric,
patient recruitment,
patient engagement,
parkinson's disease,
pal,
ots,
occupational health,
normative data,
neurotech,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
modelling,
mental wellbeing,
mental health,
mdd,
mci,
major depression,
machine learning,
ied,
high frequency,
healthcare,
guide,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ebt,
ebbinghaus,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive load,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
brain health,
biomarkers,
awards,
automatic speech recognition,
autism,
attention,
asr,
asd,
alzheimer's disease,
affective cognition,
adolescents,
absenteeism,
aaic2020,
aaic,
